Continuous glucose monitoring in type 1 diabetes.
Continuous glucose monitoring is becoming increasingly more widespread for the routine care of people with type 1 diabetes mellitus and may eventually be used in closed-loop artificial beta-cell systems. The current "state of the art" of this technology, including accuracy, performance in clinical trials, limitations, and recommendations for use, is discussed for the two currently approved continuous glucose monitoring devices.
Weinzimer
Stuart A
SA
Yale University School of Medicine, Department of Pediatrics, PO Box 208064, 333 Cedar Street, New Haven, CT 06520, USA. stuart.weinzimer@yale.edu
Tamborlane
William V
WV
Chase
H Peter
HP
Garg
Satish K
SK
D001786:Blood Glucose / Q000032:analysis; D015190:Blood Glucose Self-Monitoring / Q000191:economics / Q000295:instrumentation / Q000379:methods*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood*; D005502:Food; D006801:Humans; D007003:Hypoglycemia / Q000175:diagnosis; D007328:Insulin / Q000008:administration & dosage; D012680:Sensitivity and Specificity
D001786:Blood Glucose; D007328:Insulin